Search

Your search keyword '"Antonioli, Elisabetta"' showing total 372 results
Start Over Author "Antonioli, Elisabetta"
372 results on '"Antonioli, Elisabetta"'

51. Daratumumab, lenalidomide, and dexamethasone combination in relapsed/refractory myeloma patients: a real-life single-center experience

Author

Antonioli, Elisabetta, primary, Staderini, Michela, additional, Pilerci, Sofia, additional, Perfetto, Federico, additional, Cappelli, Francesco, additional, Allinovi, Marco, additional, Nozzoli, Chiara, additional, Attucci, Irene, additional, Buzzichelli, Alessandra, additional, Messeri, Maria, additional, and Bosi, Alberto, additional

Published
2020
Full Text
View/download PDF

53. Aggressive Disease Course of Multiple Myeloma with Concomitant ALK-Negative Anaplastic Large Cell Lymphoma: A Case Report with an Unusual Presentation

Author

Staderini, Michela, Mannelli, Lara, Antonioli, Elisabetta, Puccini, Benedetta, Berti, Valentina, Mungai, Francesco, Vergoni, Federica, Carrai, Valentina, Rigacci, Luigi, and Bosi, Alberto

Subjects
Article Subject, immune system diseases, hemic and lymphatic diseases
Abstract

ALK-negative anaplastic large cell lymphoma is a rare T-cell neoplasm with an aggressive course requiring prompt diagnostic work-up and treatment. Few cases of concomitant multiple myeloma and T-cell neoplasm are described in the literature, mainly regarding primary cutaneous anaplastic large cell lymphoma. We present the case of a 65-year-old man, simultaneously diagnosed with ALK-negative anaplastic large cell lymphoma with extranodal localization in the gastrocnemius muscle (stage 1AE) and IgG lambda multiple myeloma (ISS 2, Durie-Salmon stage 3A). Both diseases required therapeutic intervention due to the high proliferative index of lymphoma and the presence of bone lesions attributable to myeloma. The therapeutic program initially included chemotherapy (cyclophosphamide, doxorubicin, vincristine, etoposide, and prednisone; CHOEP), radiotherapy on the leg, bortezomib, and then consolidation with autologous hematopoietic stem cell transplantation. Despite being on bortezomib treatment and waiting for transplantation, the patient experienced an early myeloma progression that turned out to be refractory to second-line lenalidomide-based treatment. To our knowledge, this is the first case of concurrent diagnosis of extranodal ALK-negative anaplastic large cell lymphoma of the muscle and multiple myeloma. Simultaneous onset can be challenging for clinicians as both diseases may have an aggressive course requiring multiple treatments with increased risk of toxicity and complicated management.

Published
2020
Full Text
View/download PDF

61. Real-Rd - Real Life Italian Experience with Lenalidomide and Low-Dose Dexamethasone (Rd) As First Line Treatment of Newly-Diagnosed Multiple Myeloma Patients Not Eligible to Stem Cell Transplantation: Outcomes and Tolerability

Author

Pompa, Alessandra, primary, Conticello, Concetta, additional, Giannarelli, Diana, additional, Pettine, Loredana, additional, Paris, Laura, additional, Tognazzi, Lucia, additional, Marcatti, Magda, additional, Antonioli, Elisabetta, additional, Fioritoni, Francesca, additional, Bonalumi, Angela, additional, Mangiacavalli, Silvia, additional, Bertazzoni, Paola, additional, Vincelli, Iolanda Donatella, additional, Derudas, Daniele, additional, Siniscalchi, Agostina, additional, Pezzatti, Sara, additional, Zambello, Renato, additional, Citro, Annalisa, additional, Belotti, Angelo, additional, Lombardo, Alessandra, additional, Vozella, Federico, additional, Sementa, Adelina, additional, Consoli, Ugo, additional, Molteni, Alfredo, additional, Frungillo, Niccolò, additional, Gentile, Massimo, additional, Buda, Gabriele, additional, Aquino, Sara, additional, Palmieri, Salvatore, additional, Bongarzoni, Velia, additional, Inzoli, Alessandro, additional, Ferla, Valeria, additional, Rossi, Francesca Gaia, additional, Leotta, Valerio, additional, Romano, Alessandra, additional, Elia, Federica, additional, Del Fabro, Vittorio, additional, Montanaro, Guido, additional, Cavallaro, Francesca, additional, Galli, Monica, additional, and Baldini, Luca, additional

Published
2019
Full Text
View/download PDF

62. Myeloma plasma cell Multiparametric Flow Cytometry (MFC) detection in autograft products of Newly Diagnosed Multiple Myeloma (NDMM).

Author

Boncompagni, Riccardo, primary, Staderini, Michela, additional, Nozzoli, Chiara, additional, Antonioli, Elisabetta, additional, Caporale, Roberto, additional, Peruzzi, Benedetta, additional, Jance, Blerina, additional, Francesco, Annunziato, additional, Guidi, Stefano, additional, Gozzini, Antonella, additional, Cutini, Ilaria, additional, Serena, Mariotti, additional, Bosi, Alberto, additional, and Saccardi, Riccardo, additional

Published
2019
Full Text
View/download PDF

63. DART4MM: Daratumumab as Consolidation Therapy in Patients who Already Achieved Optimal Response /MRD Positivity by Next Generation Flow (NGF): Preliminary Results of a Phase 2 Multicenter Study

Author

Gozzetti, Alessandro, primary, Raspadori, Donatella, additional, Bacchiarri, Francesca, additional, Pacelli, Paola, additional, Di Martino, Francesca, additional, Liberati, Anna Marina, additional, Sicuranza, Anna, additional, Lombardo, Alessandra, additional, Caffarelli, Cristiana, additional, Antonioli, Elisabetta, additional, Staderini, Michela, additional, Tocci, Dania, additional, Crupi, Rosaria, additional, Bosi, Alberto, additional, and Bocchia, Monica, additional

Published
2019
Full Text
View/download PDF

64. Minimal Residual Disease (MRD) ratio before and after Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma.

Author

Boncompagni, Riccardo, primary, Staderini, Michela, additional, Nozzoli, Chiara, additional, Antonioli, Elisabetta, additional, Caporale, Roberto, additional, Peruzzi, Benedetta, additional, Cutini, Ilaria, additional, Gozzini, Antonella, additional, Serena, Mariotti, additional, Guidi, Stefano, additional, Jance, Blerina, additional, Accogli, Barbara, additional, Francesco, Annunziato, additional, Bosi, Alberto, additional, and Saccardi, Riccardo, additional

Published
2019
Full Text
View/download PDF

66. A real‐world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma.

Author

Rocchi, Serena, Tacchetti, Paola, Pantani, Lucia, Mancuso, Katia, Rizzello, Ilaria, di Giovanni Bezzi, Chiara, Scalese, Marco, Dozza, Luca, Marzocchi, Giulia, Martello, Marina, Barilà, Gregorio, Antonioli, Elisabetta, Staderini, Michela, Buda, Gabriele, Petrini, Mario, Cea, Michele, Quaresima, Micol, Furlan, Anna, Bonalumi, Angela, and Cavo, Michele

Subjects
DRUG efficacy, MULTIPLE myeloma, PROGRESSION-free survival, DEXAMETHASONE
Abstract

Carfilzomib–lenalidomide–dexamethasone (KRd) has been approved for the treatment of relapsed/refractory multiple myeloma (RRMM). We conducted a retrospective analysis of 197 RRMM patients (pts) between January 2016 and March 2018 in six Italian hematologic centers, with the aim to evaluate efficacy and safety of KRd in real‐life. At KRd initiation 27% carried high risk cytogenetic abnormalities (HRCA) [del17p and/or t(4;14) and/or t(14;16)], median number of prior lines of therapy was 2 (1–8), nearly all pts (96%) received prior bortezomib (18% refractory) while 45% were exposed to lenalidomide (R; 22% refractory). At the median of 12.5 months, 52% of the pts had discontinued treatment, mainly (66%) for progression. Main grade 3–4 adverse events were neutropenia (21%), infections (11%), and hypertension (6%). Overall, the response rate was 88%. The median progression‐free survival (PFS) was 19.8 months and 1‐year overall survival (OS) rate was 80.6%. By subgroup analysis, extended PFS and OS were observed for pts who received ≤2 prior lines of therapy (HR = 0.42, p < 0.001 and HR = 0.35, p = 0.001, respectively), not refractory to prior R (HR = 0.37, p < 0.001, and HR = 0.47, p = 0.024), without HRCA (HR = 0.33, p = 0.005 and HR = 0.26, p = 0.016) and achieving ≥ very good partial response (VGPR; HR = 0.17, p < 0.001 and HR = 0.18, p < 0.001). In conclusion, KRd demonstrated to be effective in RRMM pts treated in real‐world setting, without new safety concerns. Better survival outcomes emerged for pts with ≤2 prior lines of therapy, achieving at least a VGPR, and without HRCA. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

67. Autologous stem cell transplantation is safe in selected elderly multiple myeloma patients.

Author

Antonioli, Elisabetta, Nozzoli, Chiara, Buda, Gabriele, Staderini, Michela, Boncompagni, Riccardo, Martini, Francesca, Petrini, Mario, Bosi, Alberto, and Saccardi, Riccardo

Subjects
*STEM cell transplantation, *MULTIPLE myeloma, *PATIENT safety, *PATIENT selection, *BONE marrow transplantation, *PLASMACYTOMA
Abstract

Objectives: ASCT is currently the "gold standard" first‐line treatment for multiple myeloma patients younger than 65 years old, and limited data on efficacy and safety in older patients are available. Methods: We retrospectively analyzed a cohort of 83 newly diagnosed multiple myeloma patients aged 65 or older. All patients were evaluated for fitness at diagnosis and after bortezomib‐based induction treatment. Results and conclusions: All patients collected an adequate PBSC graft, mainly after G‐CSF plus cyclophosphamide; a median of 6.47 × 106/kg CD34 + cells was collected. The conditioning regimen consisted of melphalan 100, 140 and 200 mg/m2 in 40, 15 and 28 patients, respectively. Median time to neutrophils' and platelets' recovery was 11 and 12 days, respectively. Adverse events of any grade were referred by 40% of patients. The overall response rate was 93%, CR/sCR were 39%. Median PFS was 35 months; median OS was not reached. In our study cohort, the achievement of at least VGPR after induction therapy and the obtainment of CR/sCR after ASCT are the only parameters that were associated with an improved PFS. ASCT is an effective and safe first‐line treatment approach, a careful patients selection reduce the toxicity of the procedure. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

68. Elotuzumab, Lenalidomide, and Dexamethasone (EloRd) As Salvage Therapy for Patients with Multiple Myeloma: Italian, Multicenter, Retrospective Clinical Experience with 180 Cases Outside of Controlled Clinical Trials

Author

Gentile, Massimo, primary, Derudas, Daniele, additional, Galli, Monica, additional, Rocco, Stefano, additional, Conticello, Concetta, additional, Califano, Catello, additional, Giuliani, Nicola, additional, Mangiacavalli, Silvia, additional, Attingenti, Enrico, additional, Lombardo, Alessandra, additional, Brunori, Marino, additional, Rossi, Elena, additional, Antonioli, Elisabetta, additional, Ria, Roberto, additional, Zambello, Renato, additional, Vincelli, Donatella, additional, Bonalumi, Angela, additional, Siniscalchi, Agostina, additional, Stocchi, Raffaella, additional, Martino, Massimo, additional, Ballanti, Stelvio, additional, Gangemi, Dominella, additional, Gagliardi, Alfredo, additional, Montefusco, Vittorio, additional, Gamberi, Barbara, additional, Pompa, Alessandra, additional, Recchia, Anna, additional, Tripepi, Giovanni, additional, Frigeri, Ferdinando, additional, Bringhen, Sara, additional, Zamagni, Elena, additional, Patriarca, Francesca, additional, De Stefano, Valerio, additional, Di Raimondo, Francesco, additional, Ferrara, Felicetto, additional, Morabito, Fortunato, additional, Petrucci, Maria Teresa, additional, and Offidani, Massimo, additional

Published
2018
Full Text
View/download PDF

71. Clinical and Biological Features in Patients with Ph-Negative Chronic Myeloproliferative Neoplasm Showing Different Molecular Pattern. Comparative Study in 596 Patients of the Registro Italiano Trombocitemie (RIT)

Author

Gugliotta, Luigi, primary, Iurlo, Alessandra, additional, Gugliotta, Gabriele, additional, Tieghi, Alessia, additional, Specchia, Giorgina, additional, Gaidano, Gianluca, additional, Candoni, Anna, additional, Randi, Maria Luigia, additional, Scalzulli, Potito Rosario, additional, Dragani, Alfredo, additional, Martinelli, Vincenzo, additional, Tagariello, Giuseppe, additional, Antonioli, Elisabetta, additional, Liberati, Anna Marina, additional, Palmieri, Raffaele, additional, Langella, Maria, additional, Rago, Angela, additional, Cacciola, Rossella R, additional, Pierri, Ivana, additional, Ricco, Alessandra, additional, Cattaneo, Daniele, additional, Santoro, Umberto, additional, Rupoli, Serena, additional, Santoro, Cristina, additional, Mastrullo, Lucia, additional, Martino, Bruno, additional, Mazzucconi, Maria Gabriella, additional, Vianelli, Nicola, additional, De Stefano, Valerio, additional, Passamonti, Francesco, additional, and Vannucchi, Alessandro M., additional

Published
2015
Full Text
View/download PDF

73. Initial Therapeutic Approach and Relationship with Clinical and Biological Characteristics at Diagnosis in 2418 Patients of the Registro Italiano Trombocitemie (RIT)

Author

Gugliotta, Luigi, primary, Iurlo, Alessandra, additional, Gugliotta, Gabriele, additional, Tieghi, Alessia, additional, Candoni, Anna, additional, Cattaneo, Daniele, additional, Ricco, Alessandra, additional, Lunghi, Monia, additional, Rumi, Elisa, additional, Scalzulli, Potito Rosario, additional, Dragani, Alfredo, additional, Antonioli, Elisabetta, additional, Martinelli, Vincenzo, additional, Randi, Maria Luigia, additional, Maschio, Nilla, additional, De Biasi, Ercole, additional, Appolloni, Viviana, additional, Cantore, Nicola, additional, Palmieri, Raffaele, additional, Santoro, Cristina, additional, Polverelli, Nicola, additional, Rago, Angela, additional, Cacciola, Rossella R, additional, Villa, Maria Rosaria, additional, Codeluppi, Katia, additional, Pierri, Ivana, additional, Fama, Angelo, additional, Piccin, Andrea, additional, Martino, Bruno, additional, Vianelli, Nicola, additional, Rupoli, Serena, additional, Santoro, Umberto, additional, Miglio, Rossella, additional, Monari, Paola, additional, and Mazzucconi, Maria Gabriella, additional

Published
2014
Full Text
View/download PDF

74. Survival and Risk of Leukemic transformation in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study on 1,104 Patients

Author

Barbui, Tiziano, Thiele, Juergen, Passamonti, Francesco, Rumi, Elisa, Boveri, Emanuela, Ruggeri, Marco, Rodeghiero, Francesco, D'Amore, Emanuele, Randi, Maria Luigia, Bertozzi, Irene, Marino, Filippo, Vannucchi, Alessandro M., Antonioli, Elisabetta, Carrai, Valentina, Gisslinger, Heinz, Buxhofer-Ausch, Veronika, Muellauer, Leonhard, Carobbio, Alessandra, Gianatti, Andrea, Gangat, Naseema, Hanson, Curtis A., Tefferi, Ayalew, Barbui, Tiziano, Thiele, Juergen, Passamonti, Francesco, Rumi, Elisa, Boveri, Emanuela, Ruggeri, Marco, Rodeghiero, Francesco, D'Amore, Emanuele, Randi, Maria Luigia, Bertozzi, Irene, Marino, Filippo, Vannucchi, Alessandro M., Antonioli, Elisabetta, Carrai, Valentina, Gisslinger, Heinz, Buxhofer-Ausch, Veronika, Muellauer, Leonhard, Carobbio, Alessandra, Gianatti, Andrea, Gangat, Naseema, Hanson, Curtis A., and Tefferi, Ayalew

Published
2010

75. Thrombosis History and Relationship With Low Thrombocytosis, Leukocytosis, and Other Characteristics At Diagnosis In 977 Essential Thrombocythemia Patients A Multivariate Analysis Of The Registro Italiano Trombocitemie (RIT)

Author

Gugliotta, Luigi, primary, Iurlo, Alessandra, additional, Tieghi, Alessia, additional, Gugliotta, Gabriele, additional, Candoni, Anna, additional, Rumi, Elisa, additional, Antonioli, Elisabetta, additional, Ricco, Alessandra, additional, Lunghi, Monica, additional, Scalzulli, Rosario Potito, additional, Scortechini, Anna Rita, additional, Codeluppi, Katia, additional, Martino, Bruno, additional, Dragani, Alfredo, additional, Patriarca, Andrea, additional, Martinelli, Vincenzo, additional, Battipaglia, Giorgia, additional, Randi, Maria Luigia, additional, Cosi, Elisabetta, additional, Liberati, Anna Marina, additional, Appolloni, Viviana, additional, Maschio, Nilla, additional, Mastrullo, Lucia, additional, Villa, Maria Rosaria, additional, Esposito, Maria Rosaria, additional, Cantore, Nicola, additional, Palmieri, Fausto, additional, Langella, Maria, additional, Rivellini, Flavia, additional, Mazzucconi, Maria Gabriella, additional, Santoro, Cristina, additional, De Biasi, Ercole, additional, Rago, Angela, additional, Polverelli, Nicola, additional, Spedini, Pierangelo, additional, Cacciola, Emma, additional, Cacciola, Rossella R, additional, Pierri, Ivana, additional, Mitsheunig, Laura, additional, Salvucci, Marzia, additional, Porretto, Ferdinando, additional, Piccin, Andrea, additional, Santoro, Umberto, additional, Gaidano, Gianluca, additional, Cimino, Giuseppe, additional, Lanza, Francesco, additional, Cortelezzi, Agostino, additional, Tagariello, Giuseppe, additional, Rupoli, Serena, additional, Specchia, Giorgina, additional, Passamonti, Francesco, additional, Vannucchi, Alessandro M., additional, Pane, Fabrizio, additional, Vianelli, Nicola, additional, Miglio, Rossella, additional, and Monari, Paola, additional

Published
2013
Full Text
View/download PDF

77. Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia

Author

Vannucchi, Alessandro M., Antonioli, Elisabetta, Guglielmelli, Paola, Pancrazzi, Alessandro, Guerini, Vittoria, Barosi, Giovanni, Ruggeri, Marco, Specchia, Giorgina, Lo-Coco, Francesco, Delaini, Federica, Villani, Laura, Finotto, Silvia, Ammatuna, Emanuele, Alterini, Renato, Carrai, Valentina, Capaccioli, Gloria, Lollo, Simonetta Di, Liso, Vincenzo, Rambaldi, Alessandro, Bosi, Alberto, and Barbui, Tiziano

Published
2008
Full Text
View/download PDF

81. PRV-1, erythroid colonies and platelet Mpl are unrelated to thrombosis in essential thrombocythaemia.

Author

Vannucchi, Alessandro M, Pancrazzi, Alessandro, Antonioli, Elisabetta, Guglielmelli, Paola, Balestri, Francesca, Biscardi, Monica, Bulgarelli, Simona, Longo, Giovanni, Graziano, Claudio, Gugliotta, Luigi, Bosi, Alberto, Vannucchi, Alessandro M, Pancrazzi, Alessandro, Antonioli, Elisabetta, Guglielmelli, Paola, Balestri, Francesca, Biscardi, Monica, Bulgarelli, Simona, Longo, Giovanni, Graziano, Claudio, Gugliotta, Luigi, and Bosi, Alberto

Abstract

Udgivelsesdato: 2004-Oct, Females with the monoclonal type of essential thrombocythaemia (ET), based on the X-chromosome inactivation pattern (XCIP), have previously been shown to present a higher incidence of thrombosis than polyclonal ones. We aimed to assess correlations between XCIP, thrombosis, and three epigenetic markers of ET, namely PRV-1 overexpression, endogenous erythroid colony (EEC) formation, and reduced platelet Mpl content. Fifty-three (60%) of 88 subjects studied had monoclonal myelopoiesis and presented a 32% incidence of major thrombosis compared with 6% of polyclonal subjects (P = 0.009). The frequency of abnormalities of PRV-1, EEC, or Mpl was similar in monoclonal and polyclonal subjects (respectively, 28%, 48%, 75%, and 37%, 27%, 63%), and none of them correlated with thrombosis. We conclude that the exploited epigenetic markers constitute independent phenotypic variations and are not clustered according to monoclonality of myelopoiesis in ET; none of them could serve as a surrogate marker of thrombotic risk in male subjects with ET.

Published
2004

82. Risk Factors for Thrombosis in WHO-Defined Early/Prefibrotic Myelofibrosis: An International Study of 264 Patients,

Author

Buxhofer-Ausch, Veronika, primary, Gisslinger, Heinz, additional, Thiele, Juergen, additional, Gisslinger, Bettina, additional, Kvasnicka, Hans-Michael, additional, Müllauer, Leonhard, additional, Frantal, Sophie, additional, Carobbio, Alessandra, additional, Passamonti, Francesco, additional, Rumi, Elisa, additional, Ruggeri, Marco, additional, Rodeghiero, Francesco, additional, Randi, Maria Luigia, additional, Bertozzi, Irene, additional, Vannucchi, Alessandro M., additional, Antonioli, Elisabetta, additional, Finazzi, Guido, additional, Gangat, Naseema, additional, Tefferi, Ayalew, additional, and Barbui, Tiziano, additional

Published
2011
Full Text
View/download PDF

83. Sensitivity and Specificity of Laboratory Parameters to Detect Early/Prefibrotic Myelofibrosis in 857 Patients with Essential Thrombocythemia. A Diagnostic Algorithm

Author

Carobbio, Alessandra, primary, Finazzi, Guido, additional, Thiele, Juergen, additional, Kvasnicka, Hans-Michael, additional, Passamonti, Francesco, additional, Rumi, Elisa, additional, Ruggeri, Marco, additional, Rodeghiero, Francesco, additional, Randi, Maria Luigia, additional, Bertozzi, Irene, additional, Vannucchi, Alessandro M., additional, Antonioli, Elisabetta, additional, Gisslinger, Heinz, additional, Buxhofer-Ausch, Veronika, additional, Gangat, Naseema, additional, Rambaldi, Alessandro, additional, Tefferi, Ayalew, additional, and Barbui, Tiziano, additional

Published
2011
Full Text
View/download PDF

84. A PROGNOSTIC MODEL to PREDICT SURVIVAL In WHO-DEFINED ESSENTIAL THROMBOCYTHEMIA: A STUDY by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

Author

Passamonti, Francesco, primary, Thiele, Juergen, additional, Barbui, Tiziano, additional, Cazzola, Mario, additional, Ruggeri, Marco, additional, Rodeghiero, Francesco, additional, Randi, Marialuigia, additional, Vannucchi, Alessandro M., additional, Gisslinger, Heinz, additional, Gangat, Naseema, additional, Hanson, Curtis A, additional, Rumi, Elisa, additional, Boveri, Emanuela, additional, Carobbio, Alessandra, additional, Gianatti, Andrea, additional, D'Amore, Emanuele, additional, Bertozzi, Irene, additional, Marino, Filippo, additional, Maffioli, Margherita, additional, Caramazza, Domenica, additional, Antonioli, Elisabetta, additional, Carrai, Valentina, additional, Buxhofer-Ausch, Veronika, additional, Gisslinger, Bettina, additional, Mullauer, Leonhard, additional, Girodon, Francois, additional, Kvasnicka, hans-Michael, additional, Pascutto, Cristiana, additional, and Tefferi, Ayalew, additional

Published
2011
Full Text
View/download PDF

85. Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study

Author

Barbui, Tiziano, primary, Thiele, Juergen, additional, Passamonti, Francesco, additional, Rumi, Elisa, additional, Boveri, Emanuela, additional, Ruggeri, Marco, additional, Rodeghiero, Francesco, additional, d'Amore, Emanuele S.G., additional, Randi, Maria Luigia, additional, Bertozzi, Irene, additional, Marino, Filippo, additional, Vannucchi, Alessandro M., additional, Antonioli, Elisabetta, additional, Carrai, Valentina, additional, Gisslinger, Heinz, additional, Buxhofer-Ausch, Veronika, additional, Müllauer, Leonhard, additional, Carobbio, Alessandra, additional, Gianatti, Andrea, additional, Gangat, Naseema, additional, Hanson, Curtis A., additional, and Tefferi, Ayalew, additional

Published
2011
Full Text
View/download PDF

86. Durable Responses with the JAK1/ JAK2 Inhibitor, INCB018424, In Patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET) Refractory or Intolerant to Hydroxyurea (HU)

Author

Verstovsek, Srdan, primary, Passamonti, Francesco, additional, Rambaldi, Alessandro, additional, Barosi, Giovanni, additional, Rosen, Peter J., additional, Levy, Richard, additional, Bradley, Edward, additional, Garrett, William, additional, Vaddi, Kris, additional, Contel, Nancy, additional, Sandor, Victor, additional, Huber, Reid Michael, additional, Schacter, Lee P., additional, Rumi, Elisa, additional, Gattoni, Elisabetta, additional, Antonioli, Elisabetta, additional, Pieri, Lisa, additional, Cazzola, Mario, additional, Kantarjian, Hagop, additional, Barbui, Tiziano, additional, and Vannucchi, Alessandro M., additional

Published
2010
Full Text
View/download PDF

87. Survival and Risk of Leukemic transformation in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study on 1,104 Patients

Author

Barbui, Tiziano, primary, Thiele, Juergen, additional, Passamonti, Francesco, additional, Rumi, Elisa, additional, Boveri, Emanuela, additional, Ruggeri, Marco, additional, Rodeghiero, Francesco, additional, D'Amore, Emanuele, additional, Randi, Maria Luigia, additional, Bertozzi, Irene, additional, Marino, Filippo, additional, Vannucchi, Alessandro M., additional, Antonioli, Elisabetta, additional, Carrai, Valentina, additional, Gisslinger, Heinz, additional, Buxhofer-Ausch, Veronika, additional, Müllauer, Leonhard, additional, Carobbio, Alessandra, additional, Gianatti, Andrea, additional, Gangat, Naseema, additional, Hanson, Curtis A., additional, and Tefferi, Ayalew, additional

Published
2010
Full Text
View/download PDF

88. Changes of JAK2 V617F Allele Burden Over Time in Patients with Polycythemia Vera or Essential Thrombocythemia: A Retrospective Study of 172 Patients.

Author

Antonioli, Elisabetta, primary, Carobbio, Alessandra, additional, Pieri, Lisa, additional, Pancrazzi, Alessandro, additional, Guglielmelli, Paola, additional, Delaini, Federica, additional, Ponziani, Vanessa, additional, Susini, Maria Chiara, additional, Fjerza, Rajmonda, additional, Bosi, Alberto, additional, Rambaldi, Alessandro, additional, Barbui, Tiziano, additional, and Vannucchi, Alessandro M., additional

Published
2009
Full Text
View/download PDF

90. RAD001, An Inhibitor of mTOR, Shows Clinical Activity in a Phase I/II Study in Patients with Primary Myelofibrosis (PMF) and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis (PPV/PET MF).

Author

Vannucchi, Alessandro M., primary, Guglielmelli, Paola, additional, Gattoni, Elisabetta, additional, Antonioli, Elisabetta, additional, Bogani, Costanza, additional, Tozzi, Lorenzo, additional, Pieri, Lisa, additional, Bosi, Alberto, additional, Rambaldi, Alessandro, additional, Barbui, Tiziano, additional, and Barosi, Giovanni, additional

Published
2009
Full Text
View/download PDF

91. Increased Risk of Lymphoid Neoplasms in Patients with Philadelphia Chromosome–Negative Myeloproliferative Neoplasms

Author

Vannucchi, Alessandro M., primary, Masala, Giovanna, additional, Antonioli, Elisabetta, additional, Chiara Susini, Maria, additional, Guglielmelli, Paola, additional, Pieri, Lisa, additional, Maggi, Laura, additional, Caini, Saverio, additional, Palli, Domenico, additional, Bogani, Costanza, additional, Ponziani, Vanessa, additional, Pancrazzi, Alessandro, additional, Annunziato, Francesco, additional, and Bosi, Alberto, additional

Published
2009
Full Text
View/download PDF

92. Cytoreductive Therapeutic Approach in the Essential Thrombocythemia (ET) Patients of the Registro Italiano Trombocitemia (RIT): Preliminary Data

Author

Gugliotta, Luigi, primary, Tieghi, Alessia, primary, Candoni, Anna, primary, Lunghi, Monia, primary, Gaidano, Gianluca, primary, Passamonti, Francesco, primary, Rumi, Elisa, primary, Dragani, Alfredo, primary, Radaelli, Franca, primary, Iurlo, Alessandra, primary, Specchia, Giorgina, primary, Carluccio, Paola, primary, Scalzulli, Potito Rosario, primary, Melillo, Lorella, primary, Martinelli, Vincenzo, primary, Ciancia, Rosanna, primary, Randi, Maria Luigia, primary, Vannucchi, Alessandro, primary, Antonioli, Elisabetta, primary, De Biasi, Ercole, primary, Palmieri, Fausto, primary, Latagliata, Roberto, primary, Santoro, Cristina, primary, Liberati, Anna Marina, primary, Gubbiotti, Marta, primary, Rupoli, Serena, primary, Scortechini, Anna Rita, primary, Villa, Maria Rosaria, primary, Cacciola, Rossella R, primary, Cacciola, Emma, primary, Pierri, Ivana, primary, Salvucci, Marzia, primary, Cristofalo, Claudio, primary, Cilloni, Daniela, primary, Vianelli, Nicola, primary, Federici, Augusto B., primary, Falanga, Anna, primary, and Ruggeri, Marco, primary

Published
2008
Full Text
View/download PDF

94. Clinical Relevance of JAK2V617F Allele Burden in Primary and Post-Polycythemic/Post-Thrombocythemic Myelofibrosis

Author

Guglielmelli, Paola, primary, Barosi, Giovanni, primary, Pancrazzi, Alessandro, primary, Longo, Giovanni, primary, Antonioli, Elisabetta, primary, Pieri, Lisa, primary, Biamonte, Flavia, primary, Ponziani, Vanessa, primary, Rambaldi, Alessandro, primary, Bosi, Alberto, primary, Barbui, Tiziano, primary, and Vannucchi, Alessandro M., primary

Published
2008
Full Text
View/download PDF

95. C3-Mediated Extravascular Hemolysis as Additional Mechanism of Disease in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated by the Complent Inhibitor Eculizumab

Author

Risitano, Antonio M., primary, Marando, Ludovica, primary, Ranaldi, Danilo, primary, Seneca, Elisa, primary, Serio, Bianca, primary, Gianfaldoni, Giacomo, primary, Antonioli, Elisabetta, primary, Milano, Filippo, primary, Amendola, Angela, primary, Boschetti, Carla, primary, Barcellini, Wilma, primary, Di Bona, Eros, primary, Carella, Angelo Michele, primary, Barbano, Filippo, primary, Bonfigli, Silvana, primary, Capalbo, Silvana, primary, Fabbiano, Francesco, primary, Pulini, Stefano, primary, Marino, Antonio, primary, Pietrogrande, Francesco, primary, Iuliano, Franco, primary, Rodeghiero, Francesco, primary, Zanella, Alberto, primary, Iori, Annapaola, primary, Notaro, Rosario, primary, Luzzatto, Lucio, primary, and Rotoli, Bruno, primary

Published
2008
Full Text
View/download PDF

99. The Clinical Phenotype of Patients with Essential Thrombocythemia Harboring MPL 515W>L/K Mutation.

Author

Vannucchi, Alessandro M., primary, Antonioli, Elisabetta, additional, Pancrazzi, Alessandro, additional, Guglielmelli, Paola, additional, Di Lollo, Simonetta, additional, Alterini, Renato, additional, Guerini, Vittoria, additional, Baroni, Gianna, additional, Rambaldi, Alessandro, additional, Bosi, Alberto, additional, and Barbui, Tiziano, additional

Published
2007
Full Text
View/download PDF

100. The Registro Italiano Trombocitemie (GIMEMA Project): Preliminary Analysis of the First 801 Enrolled Patients.

Author

Gugliotta, Luigi, primary, Tieghi, Alessia, additional, Gaidano, Gianluca, additional, Franceschetti, Silvia, additional, Specchia, Giorgina, additional, Carluccio, Paola, additional, Mazzucconi, Maria Gabriella, additional, Santoro, Cristina, additional, Dragani, Alfredo, additional, Ciancia, Rosanna, additional, Candoni, Anna, additional, Palmieri, Fausto, additional, Rumi, Elisa, additional, Antonioli, Elisabetta, additional, Villa, Maria Rosaria, additional, Cilloni, Daniela, additional, Federici, Augusto, additional, Vianelli, Nicola, additional, Radaelli, Franca, additional, Randi, Maria Luigia, additional, Scalzulli, Potito, additional, Melillo, Lorella, additional, Cacciola, Emma, additional, Cacciola, Rossella, additional, and Gobbi, Marco, additional

Published
2006
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results